ZH
RU
ES

Biological medicine

Biological medicine, Total:46 items.

In the international standard classification, Biological medicine involves: Vocabularies, Water quality, Medical sciences and health care facilities in general, Pharmaceutics, Test conditions and procedures in general, Quality.

Professional Standard - Environmental Protection, Biological medicine

• HJ 1256-2022 Technical guidelines for self-monitoring of pollutant discharge units
• HJ 1062-2019 Pollutant Discharge Permit Application and Issuance Technical Specifications Pharmaceutical Industry-Biological Pharmaceutical Products Manufacturing

Professional Standard - Agriculture, Biological medicine

• 1773药典 化学药和生物制品卷-2010 Chapter 29 Pediatric Drugs Section 1 Drug Application in Neonates 2. Calculation of Drug Dose in Neonates
• 1772药典 化学药和生物制品卷-2010 Chapter 29 Pediatric Drugs Section 1 Drug Application in Newborns 1. Pharmacokinetic characteristics of newborns
• 1398药典 化学药和生物制品卷-2010 Chapter 20 Antidote Section 2 Specific Antidote VI. Drug Poisoning Antidote Vitamin B6*
• 1032药典 化学药和生物制品卷-2010 Chapter 12 Antineoplastic Drugs Section 3 Biological Targeted Therapy Drug Erlotinib
• 1031药典 化学药和生物制品卷-2010 Chapter 12 Antineoplastic Drugs Section 3 Biological Targeted Therapy Drug Gefitinib
• 1033药典 化学药和生物制品卷-2010 Chapter 12 Antineoplastic Drugs Section 3 Biological Targeted Therapy Sunitinib
• 1034药典 化学药和生物制品卷-2010 Chapter 12 Antineoplastic Drugs Section 3 Biological Targeted Therapy Ubenimex
• 1028药典 化学药和生物制品卷-2010 Chapter 12 Antineoplastic Drugs Section 3 Biological Targeted Therapy Sorafenib
• 1030药典 化学药和生物制品卷-2010 Chapter 12 Antineoplastic Drugs Section 3 Biological Targeted Therapy Drug Lapatinib
• 1029药典 化学药和生物制品卷-2010 Chapter 12 Antineoplastic Drugs Section 3 Biological Targeted Therapy Drug Imatinib
• 1027药典 化学药和生物制品卷-2010 Chapter 12 Antineoplastic Drugs Section 3 Biological Targeted Therapy Bevacizumab
• 1025药典 化学药和生物制品卷-2010 Chapter 12 Antineoplastic Drugs Section 3 Biological Targeted Therapy Drug Rituximab
• 1023药典 化学药和生物制品卷-2010 Chapter 12 Antineoplastic Drugs Section 3 Biological Targeted Therapy Trastuzumab
• 1024药典 化学药和生物制品卷-2010 Chapter 12 Antineoplastic Drugs Section 3 Biological Targeted Therapy Nimotuzumab
• 1026药典 化学药和生物制品卷-2010 Chapter 12 Antineoplastic Drugs Section 3 Biological Targeted Therapy Drug Cetuximab
• 1022药典 化学药和生物制品卷-2010 Chapter 12 Antineoplastic Drugs Section 3 Biological Targeted Therapy Drug Recombinant Human Interleukin-2
• 1775药典 化学药和生物制品卷-2010 Chapter 29 Pediatric Drugs Section 1 Drug Application for Newborns 4. Common Drugs for Neonatal Resuscitation and Reference Doses of Commonly Used Antibiotics
• 1021药典 化学药和生物制品卷-2010 Chapter 12 Antineoplastic Drugs Section 3 Biological Targeted Therapy Drugs Recombinant Human Granulocyte Macrophage Stimulating Factor
• 1681药典 化学药和生物制品卷-2010 Chapter 26 Ophthalmic Drugs Section 10 Biological Products and Biochemical Drugs Recombinant Human Interferon a1b
• 554药典 化学药和生物制品卷-2010 Chapter 7 Urinary System Drugs Section 3 Special Urinary System Drugs 1. Drugs for the treatment of benign prostatic hyperplasia (3) Natural herbal medicine Pushitai Tablets
• 555药典 化学药和生物制品卷-2010 Chapter Seven Urinary System Drugs Section Three Urinary System Special Drugs 1. Drugs for the treatment of benign prostatic hyperplasia (3) Natural herbal medicine Pygeum africanum extract*
• 1774药典 化学药和生物制品卷-2010 Chapter 29 Pediatric Drugs Section 1 Drug Application in Neonates 3. Precautions for Antibiotics Use in Neonates
• 1680药典 化学药和生物制品卷-2010 Chapter 26 Ophthalmic Drugs Section 10 Biological Products and Biochemical Drugs Recombinant Bovine Basic Fibroblast Growth Factor
• 552药典 化学药和生物制品卷-2010 Chapter VII Urinary System Medications Section III Urinary System Special Medications 1. Drugs for the treatment of benign prostatic hyperplasia (1) α-receptor antagonist tamsulosin hydrochloride
• 农业部1425号公告-3-2010 Technical guidelines for efficacy evaluation tests of antimicrobial agents for silkworms
• 549药典 化学药和生物制品卷-2010 Chapter Seven Urinary System Medications Section III Urinary System Special Medications 1. Drugs for the treatment of benign prostatic hyperplasia (1) α-receptor antagonist alfuzosin hydrochloride
• 550药典 化学药和生物制品卷-2010 Chapter Seven Urinary System Medications Section III Urinary System Special Medications 1. Drugs for the treatment of benign prostatic hyperplasia (1) α-receptor antagonist terazosin hydrochloride
• 551药典 化学药和生物制品卷-2010 Chapter VII Urinary System Drugs Section III Special Drugs for Urinary System 1. Drugs for the treatment of benign prostatic hyperplasia (1) α-receptor antagonist doxazosin mesylate
• 553药典 化学药和生物制品卷-2010 Chapter VII Urinary System Drugs Section III Urinary System Special Drugs 1. Drugs for the treatment of benign prostatic hyperplasia (2) 5α-reductase inhibitor finasteride
• 农业部1425号公告-5-2010 Technical guidelines for efficacy evaluation test of pet topical antimicrobials
• 农业部1425号公告-14-2010 Technical guidelines for the efficacy evaluation test of antimicrobial drugs for bees
• 农业部1425号公告-6-2010 Guiding principles for field test techniques for efficacy evaluation of topical antimicrobials for pets
• 农业部1425号公告-15-2010 Guiding principles for field test techniques of antimicrobial efficacy evaluation for bees

American Society for Testing and Materials (ASTM), Biological medicine

• ASTM E2363-23 Standard Terminology Relating to Manufacturing of Pharmaceutical and Biopharmaceutical Products in the Pharmaceutical and Biopharmaceutical Industry
• ASTM E2500-07(2012) Standard Guide for Specification, Design, and Verification of Pharmaceutical and Biopharmaceutical Manufacturing Systems and Equipment
• ASTM E2537-08 Standard Guide for Application of Continuous Quality Verification to Pharmaceutical and Biopharmaceutical Manufacturing
• ASTM E2537-16 Standard Guide for Application of Continuous Process Verification to Pharmaceutical and Biopharmaceutical Manufacturing
• ASTM E2500-13 Standard Guide for Specification, Design, and Verification of Pharmaceutical and Biopharmaceutical Manufacturing Systems and Equipment
• ASTM E2500-20 Standard Guide for Specification, Design, and Verification of Pharmaceutical and Biopharmaceutical Manufacturing Systems and Equipment

RU-GOST R, Biological medicine

• GOST R 57679-2017 Medicines for medical applications. Investigation bioequivalence of medications
• GOST R 56699-2015 Medicines for medical applications. Preclinical safety evaluation of biotechnology-derived pharmaceuticals. General recommendations
• GOST R 57688-2017 Medicines for medical applications. Stability testing of biotechnological/biological medications
• GOST R 57647-2017 Medicines for medical applications. Pharmacogenomics. Biomarkers

CU-NC, Biological medicine

• NC 26-92-42-1990 Drugs. Vitamin B6 Tablets Quality Specifications

Others:   Medicinal biology, Pharmacy Room, biological drug, Medicinal microorganism, Prodrug Pharmacokinetic Parameters, Beijing brand medicine, Imported medicine, Biopharmaceuticals, biological drug, Agricultural Biopharmaceuticals, Chemical and Biological Drugs, Frontiers of Biopharmaceuticals, Biological medicine, Drug dosage, drug trial drug, drug time curve, Bulk Drug Devices, API Chemicals, Upstream biopharmaceuticals, API.